Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America

New England Journal of Medicine - United States
doi 10.1056/nejmoa035026
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Massachusetts Medical Society

Related search

New Drugs for Treating Drug Resistant HIV-1

Sexually Transmitted Infections
DermatologyInfectious Diseases
2003English

Raltegravir With Optimized Background Therapy for Resistant HIV-1 Infection

New England Journal of Medicine
Medicine
2008English

Novel Central Nervous System (CNS)-Targeting Protease Inhibitors for Drug-Resistant HIV Infection and HIV-Associated CNS Complications

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

187 Drug Resistance: Crystallography of Drug-Resistant HIV-1 Protease Mutant

Journal of Biomolecular Structure and Dynamics
MedicineMolecular BiologyStructural Biology
2015English

Design, Characterization and Biopharmaceutical Behaviour of Nanoparticles Loaded With an HIV-1 Fusion Inhibitor Peptide

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2018English

An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission

Journal of Pharmaceutical Sciences
Pharmaceutical Science
2015English

Drug-Resistant Bacterial Infections in HIV Patients

2018English

Correction to Potent Inhibitor of Drug-Resistant HIV-1 Strains Identified From the Medicinal Plant Justicia Gendarussa

Journal of Natural Products
Organic ChemistryMolecular MedicinePharmacologyComplementaryPharmaceutical ScienceAnalytical ChemistryAlternative MedicineDrug Discovery
2017English

Gene Therapy for HIV-1 Infection

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy